UNLABELLED: We created SRC-1(-/-) mice by mating floxed SRC-1 mice with CMV-Cre transgenic mice. The SRC-1(-/-) mice showed high turnover osteopenia under physiological conditions and hardly responded to osteoanabolic actions of exogenous androgen and estrogen in males and females, respectively, after gonadectomies, indicating that SRC-1 is essential for the maintenance of bone mass by sex hormones. INTRODUCTION: Steroid receptor coactivator-1 (SRC-1) is the first identified coactivator of nuclear receptors. This study investigated the role of SRC-1 in skeletal tissues of males and females using the deficient (SRC-1(-/-)) mice. MATERIALS AND METHODS: SRC-1(-/-) mice were generated by mating our original floxed SRC-1 mice with CMV-Cre transgenic mice. Bone metabolism between 24-week-old SRC-1(-/-) and wildtype (WT) littermates under physiological conditions was compared in males and females by radiological, histological, and biochemical analyses. Difference of skeletal responses to steroid hormones was examined by gonadectomies and exogenous administration experiments with the hormones. Statistical analysis was performed by ANOVA determined by posthoc testing using Bonferroni's method. RESULTS AND CONCLUSIONS: Although SRC-1(-/-) mice showed no abnormality in growth or major organs, both males and females showed osteopenia with high bone turnover in the trabecular bones, but not in the cortical bones, compared with WT littermates. Their serum levels of sex hormones were upregulated, suggesting a compensatory reaction for the insensitivity to these hormones. Gonadectomies caused decreases in BMDs of SRC-1(-/-) and WT mice to the same levels; however, replacement with 5 alpha-dihydrotestosterone and 17 beta-estradiol in males and females, respectively, failed to restore the bone loss in SRC-1(-/-), whereas the WT bone volume was increased to the sham-operated levels. In contrast, bone loss by administered prednisolone was similarly seen in SRC-1(-/-) and WT mice. We conclude that SRC-1 is essential for the maintenance of bone mass by sex hormones, but not for the catabolic action of glucocorticoid, under both physiological and pathological conditions.
UNLABELLED: We created SRC-1(-/-) mice by mating floxed SRC-1mice with CMV-Cre transgenic mice. The SRC-1(-/-) mice showed high turnover osteopenia under physiological conditions and hardly responded to osteoanabolic actions of exogenous androgen and estrogen in males and females, respectively, after gonadectomies, indicating that SRC-1 is essential for the maintenance of bone mass by sex hormones. INTRODUCTION:Steroid receptor coactivator-1 (SRC-1) is the first identified coactivator of nuclear receptors. This study investigated the role of SRC-1 in skeletal tissues of males and females using the deficient (SRC-1(-/-)) mice. MATERIALS AND METHODS:SRC-1(-/-) mice were generated by mating our original floxed SRC-1mice with CMV-Cre transgenic mice. Bone metabolism between 24-week-old SRC-1(-/-) and wildtype (WT) littermates under physiological conditions was compared in males and females by radiological, histological, and biochemical analyses. Difference of skeletal responses to steroid hormones was examined by gonadectomies and exogenous administration experiments with the hormones. Statistical analysis was performed by ANOVA determined by posthoc testing using Bonferroni's method. RESULTS AND CONCLUSIONS: Although SRC-1(-/-) mice showed no abnormality in growth or major organs, both males and females showed osteopenia with high bone turnover in the trabecular bones, but not in the cortical bones, compared with WT littermates. Their serum levels of sex hormones were upregulated, suggesting a compensatory reaction for the insensitivity to these hormones. Gonadectomies caused decreases in BMDs of SRC-1(-/-) and WT mice to the same levels; however, replacement with 5 alpha-dihydrotestosterone and 17 beta-estradiol in males and females, respectively, failed to restore the bone loss in SRC-1(-/-), whereas the WT bone volume was increased to the sham-operated levels. In contrast, bone loss by administered prednisolone was similarly seen in SRC-1(-/-) and WT mice. We conclude that SRC-1 is essential for the maintenance of bone mass by sex hormones, but not for the catabolic action of glucocorticoid, under both physiological and pathological conditions.
Authors: Jennifer L Cantley; Daniel F Vatner; Thomas Galbo; Anila Madiraju; Max Petersen; Rachel J Perry; Naoki Kumashiro; Fitsum Guebre-Egziabher; Arijeet K Gattu; Mitchel R Stacy; Donald P Dione; Albert J Sinusas; Louis Ragolia; Christopher E Hall; Vara Prasad Manchem; Sanjay Bhanot; Jonathan S Bogan; Varman T Samuel Journal: Am J Physiol Endocrinol Metab Date: 2014-08-26 Impact factor: 4.310
Authors: Jean-Francois Louet; Atul R Chopra; Jorn V Sagen; Jie An; Brian York; Mounia Tannour-Louet; Pradip K Saha; Robert D Stevens; Brett R Wenner; Olga R Ilkayeva; James R Bain; Suoling Zhou; Franco DeMayo; Jianming Xu; Christopher B Newgard; Bert W O'Malley Journal: Cell Metab Date: 2010-12-01 Impact factor: 27.287
Authors: Maria Almeida; Michaël R Laurent; Vanessa Dubois; Frank Claessens; Charles A O'Brien; Roger Bouillon; Dirk Vanderschueren; Stavros C Manolagas Journal: Physiol Rev Date: 2017-01 Impact factor: 37.312
Authors: R J Hartmaier; A S Richter; R M Gillihan; J Z Sallit; S E McGuire; J Wang; A V Lee; C K Osborne; B W O'Malley; P H Brown; J Xu; T C Skaar; S Philips; J M Rae; F Azzouz; L Li; J Hayden; N L Henry; A T Nguyen; V Stearns; D F Hayes; D A Flockhart; S Oesterreich Journal: Mol Endocrinol Date: 2011-12-15
Authors: Ulrike I Mödder; David G Monroe; Daniel G Fraser; Thomas C Spelsberg; Clifford J Rosen; Martine Géhin; Pierre Chambon; Bert W O'Malley; Sundeep Khosla Journal: J Biol Chem Date: 2009-05-07 Impact factor: 5.157